Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 6Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Neoplasms, Neuroepithelial 1Neoplasm Metastasis 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Leukemia, T-Cell 1Leukemia, Lymphoid 1Glioblastoma 1Choroid Plexus Neoplasms 1CCND1 Gene Amplification 1Breast Neoplasm Female 1Breast Cancer Recurrent 1Astrocytoma 1

Interventions

Cytarabine 2pegaspargase 1palbociclib 1carmustine, poliferprosan 20 drug combination 1Vincristine 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Prednisone 1Prednisolone 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Hydrocortisone 1Hematopoietic Stem Cell Mobilization 1Etoposide 1Drug Therapy 1Doxorubicin 1Carmustine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, T-Cell × palbociclib × Clear all
NCT03792256 2025-03-21

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Children's Oncology Group

Phase 1 Completed
12 enrolled 24 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Recurrence, Leukemia, T-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡